Liraglutide does not increase heart rate of diabetic patients during acute myocardial infarction
{{output}}
Background: Glucagon-like peptide 1 receptor agonists have been shown to reduce all-cause and cardiovascular mortality in patients with Type 2 diabetes mellitus (T2DM). The probable increase in heart rate hinders its early usage ... ...
